Laine Celestino Pinto et al., 2015-12: Brazilian study of mebendazole against human malignant-ascites cell lines derived from gastric cancer, reporting low-micromolar cytotoxicity, microtubule disruption and reduced invasion and MMP-2 activity.
Our data reveal that MBZ showed high cytotoxicity in vitro, displaying an IC50 of 0.39 μM and 1.25 μM in ACP-02 and ACP-03, respectively.
Laine Celestino Pinto et al., 2015-12: Brazilian study of mebendazole against human malignant-ascites cell lines derived from gastric cancer, reporting low-micromolar cytotoxicity, microtubule disruption and reduced invasion and MMP-2 activity. Study type: gastric cancer cell lines in vitro (ACP-02, ACP-03, AGP-01). N: not applicable. Country: Brazil (Federal University of Para, Belem). Dose: IC50 0.39 and 1.25 micromolar. Funder: not stated in the record. Declared conflicts: no COI statement in the record. Comparator: 5-fluorouracil alone and in combination, and negative controls. This is the only gastric-cancer document in this sweep: it is cell-line work, so C6's gastric arm has no animal study behind it in this record. Study type: lab.
